Abstract:Globally, cancer is the most prevalent chronic disease-related cause of death. Although there are many anticancer drugs, some of them have adverse effects. Due to their limited side effects, natural products are preferred over synthetic drugs. Andrographolide and its derivatives are known to be potent anticancer agents. In this context, sixteen novel 3,19-(NH-3-aryl-pyrazole) acetals of andrographolide and isoandrographolide (1a-1h, 2a-2g, 2i) from 3-aryl-1-H-pyrazole-4-carboxaldehydes (a-i) were synthesized. All the synthesized compounds were characterized using 1H NMR, 13C NMR, HRMS, FT-IR, and UV-vis spectroscopy. All the compounds were evaluated against a panel of 60 different human cancer cell lines for their anticancer potential at NCI, USA. Four compounds, having promising GI50s (50% growth inhibitory activity) on all 60-cell lines were selected for further in vitro studies. Out of these four compounds, compound 1g exhibited the best IC50 (3.08 μM) against the colon cancer cell line, HCT-116. Cell cycle analysis, annexin V-FITC/PI, and ROS assays revealed that the apoptosis of HCT-116 cells induced by compound 1g could be mainly attributed to the elevated levels of intracellular ROS. Further, the structure-activity relationship revealed that the pyrazole moiety of andrographolide plays a key role in their anticancer properties. These compounds were further examined for in silico ADMET and Lipinski characteristics to assess their potential as lead compounds.

Synthesis and Antitumor Activity of N-Acetyl-12-aminomethyl-14-deoxy Andrographolide Derivatives

Design and Synthesis of Novel Dehydroepiandrosterone Analogues As Potent Antiproliferative Agents

Synthesis and biological evaluation of novel podophyllotoxin analogs as antitumor agents.

Synthesis of Flavone Derivatives via N-Amination and Evaluation of Their Anticancer Activities

Antitumor Agents 288: Design, Synthesis, SAR, and Biological Studies of Novel Heteroatom-Incorporated Antofine and Cryptopleurine Analogues As Potent and Selective Antitumor Agents.

Synthesis and Anti-tumor Activity of Novel 2-Amino-1,3,4-thiadiazole Derivativers

Synthesis and Antitumor Activity of Hederagenin Derivatives

Anti-cancer activity of heteroaromatic acetals of andrographolide and its isomers

Synthesis of novel pyrazole acetals of andrographolide and isoandrographolide as potent anticancer agents

Design, Syntheses and Biological Evaluation of Natural Product Aiphanol Derivatives and Analogues: Discovery of Potent Anticancer Agents

Synthesis and cytotoxicity of novel 14α-O-(andrographolide-3-subsitutedisoxazole-5-carboxylate) derivatives

Synthesis and antitumor activity evaluation of a novel series of xanthone derivatives

Synthesis and Antitumor Evaluation of Novel 5-Hydrosulfonyl-1h-benzo[d]imidazol-2(3h)-one Derivatives.

Design, synthesis, and antitumor activity of novel oleanolic acid analogues targeting EGFR

Design, synthesis and biological evaluation of valepotriate derivatives as novel antitumor agents

Design, synthesis, and anti-cancer evaluation of C-14 arylcarbamate derivatives of andrographolide

Synthesis and Antitumor Activity of 6- and 2-（1-Acylsulfanylalkyl）-5,8-dimethoxy-1,4-naphthoquinones

Synthesis, Docking and Biological Evaluation of Isoquinolonic Acid Derivatives

Synthesis and biological evaluation of novel Jiyuan Oridonin A-1,2,3-triazole-azole derivatives as antiproliferative agents.

Synthesis and biological evaluation of the novel antitumor agent 3'-monosubstituted chalcone derivatives

Design, synthesis and in vitro evaluation of tylophorine derivatives as possible anti-tumor agents.